MedTrace Logo

Observational Study in Japanese Type 2 Diabetes Patients

NCT01055808 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 677

Last updated 2010-12-10

No results posted yet for this study

Summary

This study is designed to address the gap in the literature related to changing treatment regimen or formulation between different types of insulin, and how this change impacts quality of life, adherence, individual patient treatment satisfaction and glycemic control.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

DRUG

Insulins

Individual dose and frequency and duration as determined by the treating physician

Sponsors & Collaborators

Principal Investigators

  • Call 1-877-CTLILLY(1-877-285-4559) or 1-317-615-4559 Mon - Fri from 9AM-5PM Eastern time (UTC/GMT - 5 hours, EST) · Eli Lilly and Company

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • Japan

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01055808 on ClinicalTrials.gov